6,330.00
-10(-0.16%)
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
592
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Mr. Nobumasa Kondo | Chief Executive Officer, President & Representative Director | 0 | 1968 |
| Mr. Yukihiro Takashima | General Manager of Finance & Accounting Department | 0 | N/A |
| Yuichiro Takeuchi | Executive Officer and Head of Pharmaceutical Marketing & Promotion Group | 0 | N/A |
| Noriaki Nishino | Executive Officer, Head of Pharmacovigilance & Quality Assu Grp and Quality Assurance Grp Leader | 0 | N/A |
| Mr. Katsunobu Fujiwara | Head of Pharmaceutical Marketing & Promotion Group and Director | 0 | 1963 |
| Shinichiro Arikawa | Senior Executive Officer and Head of Planning & Administration Group | 0 | N/A |
| Gen Matsuo | Executive Officer & Head of Innovation Group | 0 | N/A |
| Koji Matsuda | Executive Officer & Head of Production Group | 0 | N/A |
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.